Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
28.98
+1.74 (6.39%)
At close: Mar 9, 2026, 4:00 PM EDT
28.98
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT
Travere Therapeutics Employees
Travere Therapeutics had 497 employees as of December 31, 2025. The number of employees increased by 112 or 29.09% compared to the previous year.
Employees
497
Change (1Y)
112
Growth (1Y)
29.09%
Revenue / Employee
$987,380
Profits / Employee
-$51,400
Market Cap
2.68B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Apellis Pharmaceuticals | 739 |
| Adaptive Biotechnologies | 624 |
| Arcus Biosciences | 601 |
| Beam Therapeutics | 511 |
| Wave Life Sciences | 317 |
| Dyne Therapeutics | 258 |
| Vera Therapeutics | 224 |
TVTX News
- 13 days ago - Travere Therapeutics: FILSPARI Drives Revenue, FSGS PDUFA Looms - Seeking Alpha
- 17 days ago - Travere Therapeutics, Inc. (TVTX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 24 days ago - Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 25 days ago - Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit - Business Wire
- 5 weeks ago - Travere Therapeutics: Filspari's FSGS Approval Chance Is Higher Than You Think - Seeking Alpha
- 5 weeks ago - TVTX: Travere Therapeutics Shareholders Should Contact Block & Leviton To Potentially Recover Losses - GlobeNewsWire